X4 Pharmaceuticals Partners with K2 HealthVentures to Secure Up to $150 Million Senior Debt Facility.
Amount Raised
$150 Million
Round Type
Debt Financing
BostonBiotechnologyHealthcareDescription
X4 Pharmaceuticals has entered into a partnership with K2 HealthVentures to secure a senior secured term loan facility of up to $150 million. This funding will enhance X4’s financial flexibility and supports the advancement of mavorixafor towards FDA approval and its commercial launch.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as X4 Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Equinox raised $1B on November 2, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Araceli Biosciences raised $4.5M (Seed) on October 20, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- CollPlant Biotechnologies Ltd raised $9.2M on October 9, 2026.
Who to call at X4 Pharmaceuticals, and when
A new round usually means X4 Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day X4 Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at X4 Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at X4 Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment X4 Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
X4 Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.